Thursday, June 26, 2025 6/26/2025

REGULATION OF T CELL IMMUNITY TO INFLUENZA BY CD44

Award Number: R01AI061615
ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 07/01/2009
PERIOD OF PERFORMANCE END DATE: 06/30/2010

Group Awards By:

View Award Description

REGULATION OF T CELL IMMUNITY TO INFLUENZA BY CD44 - DESCRIPTION (provided by applicant): The lung is the site of infection by influenza (flu) virus which gains access to airways by aerosol transmission. This infection is confined to lung epithelium, and its control depends upon an effective, local immune response that is mediated by CD4 and CD8 cells. Protective immunity is associated with flu-specific CD4 and CD8 cells that persist for extended durations in airways. Thus, optimal vaccine development to organisms such as flu that could be used for bioterrorism will depend upon greater understanding of the requirements for generating effector cells with the capacity to migrate into, as well as respond and persist in the target tissue. CD44, the product of a single gene that is subject to mRNA splicing and post translational modifications, is a key regulator of inflammatory processes in the lung. Expression of high levels of CD44 is the most widely used marker to distinguish effector and memory T cells from naive T cells, yet little is known regarding it's function in Ag-experienced cells. Our preliminary studies of responses to flu using CD44- deficient mice and CD44-blocking antibodies support the hypothesis that CD44 is essential for T cell migration into lung airways, and provide evidence for additional roles in regulating the responses and survival of effector and memory cells. We have developed adoptive transfer models with TCR transgenic CD4 and CD8 cells with which we can induce and track Ag-specific T cell responses to engineered flu viruses that express the appropriate peptides. With Class I and Class 1I multimers and cytokine reporter mice we can also follow responses ofpolyclonal T cells. With these tools, we propose to investigate mechanisms by which CD44 can contribute to T cell immunity to flu. Aim 1 will test the hypothesis that CD44 mediates an essential adhesion mechanism that enables the transmigration of effector T cells into the airways in response to infection and functions in the maintenance of flu-specific T cells in this site. Aim 2 will test the hypothesis that CD44 regulates cytokine production by effectors, and supports their appropriate expansion and responses to flu within the lung. Aim 3 will investigate the role of CD44 in regulation of the homeostasis oft cell subsets. We believe that these studies will provide new insights into mechanisms by which adhesion pathways and interactions with extracellular matrix components can affect the optimal development of T cell responses in target tissues as well as the longevity of memory.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2009 ( Subtotal = -$951 )
2009	2008	BURNHAM INSTITUTE FOR MEDICAL RESEARCH	10901 NORTH TORREY PINES ROAD	LA JOLLA	CA	92037	SAN DIEGO	USA	Allergy and Infectious Diseases Research	002	6	9/17/2009	CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION	$117,231
2009	2008	SIDNEY KIMMEL CANCER CENTER	10905 Road To The Cure	San Diego	CA	92121	SAN DIEGO	USA	Allergy and Infectious Diseases Research	001	5	9/17/2009	NON-COMPETING CONTINUATION	-$111,236
2009	2008	SIDNEY KIMMEL CANCER CENTER	10905 Road To The Cure	San Diego	CA	92121	SAN DIEGO	USA	Allergy and Infectious Diseases Research	000	5	8/20/2009	NON-COMPETING CONTINUATION	-$6,946
														Subtotal = -$951

Issue Date FY: 2008 ( Subtotal = $440,170 )
2008	2008	SIDNEY KIMMEL CANCER CENTER	10835 ALTMAN ROW	SAN DIEGO	CA	92121	SAN DIEGO	USA	Allergy and Infectious Diseases Research	000	5	6/25/2008	NON-COMPETING CONTINUATION	$440,170
														Subtotal = $440,170

Issue Date FY: 2007 ( Subtotal = $448,695 )
2007	2007	SIDNEY KIMMEL CANCER CENTER	10835 ALTMAN ROW	SAN DIEGO	CA	92121	SAN DIEGO	USA	Allergy and Infectious Diseases Research	000	4	6/20/2007	NON-COMPETING CONTINUATION	$448,695
														Subtotal = $448,695

Issue Date FY: 2006 ( Subtotal = $454,805 )
2006	2006	SIDNEY KIMMEL CANCER CENTER	10835 ALTMAN ROW	SAN DIEGO	CA	92121	SAN DIEGO	USA	Allergy and Infectious Diseases Research	000	3	6/14/2006	NON-COMPETING CONTINUATION	$454,805
														Subtotal = $454,805

Issue Date FY: 2005 ( Subtotal = $465,750 )
2005	2005	SIDNEY KIMMEL CANCER CENTER	10835 ALTMAN ROW	SAN DIEGO	CA	92121	SAN DIEGO	USA	Microbiology and Infectious Diseases Research	000	2	6/17/2005	NON-COMPETING CONTINUATION	$465,750
														Subtotal = $465,750

Issue Date FY: 2004 ( Subtotal = $465,750 )
2004	2004	SIDNEY KIMMEL CANCER CENTER	10835 ALTMAN ROW	SAN DIEGO	CA	92121	SAN DIEGO	USA	Microbiology and Infectious Diseases Research	000	1	4/16/2004	NEW	$465,750
														Subtotal = $465,750

Grand Total All Awards = $2,274,219

Top

All Categories

About

Search

Reports

Data Submission

Award Information

REGULATION OF T CELL IMMUNITY TO INFLUENZA BY CD44

Award Number: R01AI061615

ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 07/01/2009

PERIOD OF PERFORMANCE END DATE: 06/30/2010

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer